日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients

B4GALT1 表达可预测肌层浸润性膀胱癌患者的预后和辅助化疗益处

Huyang Xie, Yu Zhu, Junyu Zhang, Zheng Liu, Hangcheng Fu, Yifan Cao, Gaoxiang Li, Yijun Shen, Bo Dai, Jiejie Xu, Dingwei Ye

Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer

肿瘤基质浸润肥大细胞预测肌层浸润性膀胱癌患者的预后和辅助化疗益处

Zheng Liu, Yu Zhu, Le Xu, Junyu Zhang, Huyang Xie, Hangcheng Fu, Quan Zhou, Yuan Chang, Bo Dai, Jiejie Xu

A three-molecule score based on Notch pathway predicts poor prognosis in non-metastasis clear cell renal cell carcinoma

基于 Notch 通路的三分子评分可预测非转移性透明细胞肾细胞癌的不良预后

Zheng Liu, Qiang Fu, Hangcheng Fu, Zewei Wang, Le Xu, Huimin An, Yanfeng Li, Jiejie Xu

CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma

CCL2/CCR2 轴与非转移性透明细胞肾细胞癌患者术后生存和复发相关

Zewei Wang, Huyang Xie, Lin Zhou, Zheng Liu, Hangcheng Fu, Yu Zhu, Le Xu, Jiejie Xu

High expression of galectin-7 associates with poor overall survival in patients with non-metastatic clear-cell renal cell carcinoma

半乳糖凝集素 7 高表达与非转移性透明细胞肾细胞癌患者总体生存率低相关

Jieti Wang, Yidong Liu, Yuanfeng Yang, Zhiying Xu, Guodong Zhang, Zheng Liu, Hangcheng Fu, Zewei Wang, Haiou Liu, Jiejie Xu

Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma

B4GALT1 表达增加与非转移性透明细胞肾细胞癌患者的不良预后相关

Huyang Xie, Yu Zhu, Huimin An, Hongkai Wang, Yao Zhu, Hangcheng Fu, Zewei Wang, Qiang Fu, Jiejie Xu, Dingwei Ye

Prognostic value of interleukin-6 and interleukin-6 receptor in organ-confined clear-cell renal cell carcinoma: a 5-year conditional cancer-specific survival analysis

白细胞介素 6 和白细胞介素 6 受体对器官局限性透明细胞肾细胞癌的预后价值:5 年条件癌症特异性生存分析

Qiang Fu, Yuan Chang, Huimin An, Hangcheng Fu, Yu Zhu, Le Xu, Weijuan Zhang, Jiejie Xu